Conclusion: In conclusion, our study comprehensively analyzed the clinical value of SLC12A9 and its potential mechanism, as well as immune cell infiltration, which may accelerate the diagnosis and improve the prognosis of CRC. The gene discussed is SLC12A9; the disease is colorectal carcinoma.